Andrew Hughes

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

Matthew Krebs, Robert Szczepaniak‐Sloane, Lynsey Priest et al. · Journal of Clinical Oncology · 2011 · 865 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

Matthew Krebs, Jianmei Hou, Robert Szczepaniak‐Sloane et al. · Journal of Thoracic Oncology · 2011 · 468 citations · Full text

Medicine, Cell Biology, Oncology +14

Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer

Jianmei Hou, Matthew Krebs, Tim Ward et al. · American Journal Of Pathology · 2011 · 441 citations · Full text

Medicine, Cancer Biology, Oncology +16

Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study

Dominic G. Rothwell, Mahmood Ayub, Natalie Cook et al. · Nature Medicine · 2019 · 306 citations · Full text

Medicine, Oncology, Radiology +10

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer

Louise Carter, Dominic G. Rothwell, Bárbara Mesquita et al. · Nature Medicine · 2016 · 302 citations

Medicine, Molecular Genetics, Oncology +17